Publicaciones en colaboración con investigadores/as de University Medical Center Freiburg (11)

2024

  1. Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1

    EMBO molecular medicine, Vol. 16, Núm. 1, pp. 112-131

2023

  1. Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi

    Molecular Therapy Nucleic Acids, Vol. 34

2022

  1. Neoantigens as potential vaccines in hepatocellular carcinoma

    Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 2

2021

  1. Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage

    Blood Cancer Journal, Vol. 11, Núm. 12

2018

  1. Diagnosis, treatment, and response assessment in solitary plasmacytoma: Updated recommendations from a European Expert Panel

    Journal of Hematology and Oncology, Vol. 11, Núm. 1

  2. The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma

    Neuro-Oncology, Vol. 20, Núm. 7, pp. 930-941

2017

  1. Is immunotherapy here to stay in multiple myeloma?

    Haematologica, Vol. 102, Núm. 3, pp. 423-432

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

  2. Tim-3 expression in Tumour-associated macrophages: A new player in HCC progression

    Gut

2013

  1. FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo

    PLoS ONE, Vol. 8, Núm. 1

2012

  1. Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma

    Nature Genetics, Vol. 44, Núm. 3, pp. 323-327